S&P 5007,490+0.70%
NASDAQ25,374+1.00%
DOW52,485+0.53%
NIFTY 5024,384+0.27%
SENSEX78,095+0.21%
FTSE 10010,868-0.27%
NIKKEI64,362+4.03%
VIX15.99-6.44%
BTC$62,711-0.74%
GOLD$4,107-1.29%
BRENT$90.12+1.22%
10Y UST4.75%+1.76%
S&P 5007,490+0.70%
NASDAQ25,374+1.00%
DOW52,485+0.53%
NIFTY 5024,384+0.27%
SENSEX78,095+0.21%
FTSE 10010,868-0.27%
NIKKEI64,362+4.03%
VIX15.99-6.44%
BTC$62,711-0.74%
GOLD$4,107-1.29%
BRENT$90.12+1.22%
10Y UST4.75%+1.76%
Today's moversNVDA+2.93%AMD-1.90%PLTR+0.65%TSLA+0.76%ASTS+0.92%RKLB+0.42%RELIANCE.NS+1.15%
Live market data · last updated 01 Aug, 17:35 UTC·Quotes may be delayed up to ~15 minutes. For research only, not trading.

SUNPHARMA.NS — Sun Pharmaceutical Industries Limited Stock Analysis

Live price, valuation snapshot, analyst targets, financial summary, ownership and risks for Sun Pharmaceutical Industries Limited · Healthcare. Research only — not investment advice.

Price ₹1990.50Analyst target ₹2047.97P/E 39.5Mkt cap ₹4775.9B
Quick:

Charts for this listing are drawn by the Quantifi engine (Yahoo data) — TradingView’s free widget doesn’t carry non-US symbols.

Loading analysis…

SUNPHARMA.NS — frequently asked

What is SUNPHARMA.NS (Sun Pharmaceutical Industries Limited)?

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsych

Is SUNPHARMA.NS a good investment?

Quantifi does not say whether any stock is a buy. It gives you the data — valuation vs analyst targets, financial health, ownership and risks — so you can do your own research. Research only, not investment advice.

How is SUNPHARMA.NS valued?

The analysis compares the current price against analysts' price targets and a cash-flow-based fair-value estimate, alongside a financial-health scorecard. Valuations move daily.

Is there recent insider trading activity in SUNPHARMA.NS?

Quantifi surfaces SUNPHARMA.NS insider activity from SEC Form 4 filings — who bought or sold, how many shares and at what price — as research context. Open the Insider Activity page for the latest filings. Insider transactions are one signal among many, not a recommendation.

Where can I see SUNPHARMA.NS SEC filings and financials?

SUNPHARMA.NS's financial summary, ownership and insider (Form 4) activity on Quantifi are built from public SEC and market-data sources. Use them as a starting point and confirm against the company's official SEC EDGAR filings before acting.

Does Quantifi give buy or sell signals for SUNPHARMA.NS?

No. Quantifi is research and education only. It does not execute trades or provide guaranteed returns.

Research tools

Insider Activity (SEC Form 4)DCF CalculatorPortfolio Risk AnalyzerStock ScreenerResearch Ideas

Research only. Not investment advice. Quantifi does not execute trades or provide guaranteed returns. Market data may be delayed and is provided on a best-efforts basis for educational use.